{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T01:04:31Z","timestamp":1777511071442,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005626","name":"Universit\u00e4t Regensburg","doi-asserted-by":"publisher","award":["ReForM programm"],"award-info":[{"award-number":["ReForM programm"]}],"id":[{"id":"10.13039\/501100005626","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005296","name":"Universit\u00e4tsklinikum Regensburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005296","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Administering antithrombotic therapy (ATT) in patients with infective endocarditis (IE) involves a complex balance of bleeding and thromboembolic risks. Data on outcomes beyond the acute phase remain limited. This retrospective single-center cohort study had two aims: first, to describe the use of anticoagulation during the acute phase of left-sided IE; and second, to examine, without inferring causality, how anticoagulation, as used in routine care, correlated with in-hospital and long-term clinical outcomes, including mortality and neurological events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>ATT in patients with left-sided IE was assessed retrospectively and categorized into two groups: any therapy that included anticoagulation (AC) and therapy without anticoagulation (No-AC). Two observational periods were analyzed: the in-hospital phase and the period beginning 3\u00a0months after discharge, when 30% of patients had their ATT modified. Vital and neurological status were obtained by standardized telephone follow-up (mean follow-up time 4.2\u2009\u00b1\u20093.1\u00a0years). Log-rank tests, Kaplan\u2013Meier estimates, Cox regression analyses, and matched analyses were used to explore correlations between ATT and these outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 504 hospitalized patients (mean age 65\u2009\u00b1\u200913\u00a0years, 25% female) with left-sided IE were included. During inpatient treatment, 83 patients (16%) died, with no relevant difference between AC and No-AC groups. During follow-up, patients in the AC group showed a more favorable value for the combined endpoint of mortality and unfavorable neurological function (P\u2009=\u20090.029) that was driven primarily by higher survival rates (P\u2009&lt;\u20090.001). In Cox regression analyses, higher age, CHA\u2082DS\u2082-VA score, EuroSCORE II, Staphylococcus aureus bacteremia, and atrial fibrillation were each linked to a higher hazard of the combined endpoint, whereas AC showed an inverse correlation. Consecutive matched analyses yielded similar results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this retrospective cohort, anticoagulated patients did not show a higher rate of adverse events during hospitalization and had a lower long-term event rate. These findings represent correlations observed in a non-randomized, single-center setting and may partly reflect differences in underlying risk profiles and treatment selection (confounding by indication and residual confounding). Prospective studies are needed to confirm any causal effects and to define more precisely the role of ATT in patients with IE and elevated cardiovascular risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s00392-026-02859-w","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T09:37:11Z","timestamp":1770629831000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antithrombotic therapy in infective endocarditis: Long-term clinical outcomes of a retrospective cohort study"],"prefix":"10.1007","author":[{"given":"Carlotta","family":"Posner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias","family":"F\u00fcssl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Firat","family":"Koyun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kostiantyn","family":"Kozakov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Heuer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Hitzenbichler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jozef","family":"Micek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukas","family":"Kr\u00e4mer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiba","family":"Daas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel T.","family":"Sossalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars S.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt","family":"Debl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Schlachetzki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9560-4015","authenticated-orcid":false,"given":"Christian","family":"Schach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"issue":"10","key":"2859_CR1","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41569-019-0215-0","volume":"16","author":"B Iung","year":"2019","unstructured":"Iung B, Duval X (2019) Infective endocarditis: innovations in the management of an old disease. Nat Rev Cardiol 16(10):623\u2013635","journal-title":"Nat Rev Cardiol"},{"key":"2859_CR2","doi-asserted-by":"crossref","unstructured":"Habib G et al (2015) ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 36 (44):3075\u2013128.","DOI":"10.1093\/eurheartj\/ehv319"},{"key":"2859_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.774224","author":"H Chen","year":"2022","unstructured":"Chen H et al (2022) The global, regional, and national burden and trends of infective endocarditis from 1990 to 2019: results from the Global Burden of Disease Study 2019. Front Med (Lausanne). https:\/\/doi.org\/10.3389\/fmed.2022.774224","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"2859_CR4","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jacc.2016.10.066","volume":"69","author":"TJ Cahill","year":"2017","unstructured":"Cahill TJ et al (2017) Challenges in infective endocarditis. J Am Coll Cardiol 69(3):325\u2013344","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"2859_CR5","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","volume":"132","author":"LM Baddour","year":"2015","unstructured":"Baddour LM et al (2015) Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation 132(15):1435\u20131486","journal-title":"Circulation"},{"issue":"23","key":"2859_CR6","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1161\/CIRCULATIONAHA.112.000813","volume":"127","author":"E Garcia-Cabrera","year":"2013","unstructured":"Garcia-Cabrera E et al (2013) Neurological complications of infective endocarditis: risk factors, outcome, and impact of cardiac surgery: a multicenter observational study. Circulation 127(23):2272\u20132284","journal-title":"Circulation"},{"issue":"4","key":"2859_CR7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/1941874414537077","volume":"4","author":"NA Morris","year":"2014","unstructured":"Morris NA et al (2014) Neurologic complications in infective endocarditis: identification, management, and impact on cardiac surgery. Neurohospitalist 4(4):213\u2013222","journal-title":"Neurohospitalist"},{"issue":"7","key":"2859_CR8","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1161\/CIRCULATIONAHA.108.834432","volume":"120","author":"HA Cooper","year":"2009","unstructured":"Cooper HA et al (2009) Subclinical brain embolization in left-sided infective endocarditis: results from the evaluation by MRI of the brains of patients with left-sided intracardiac solid masses (EMBOLISM) pilot study. Circulation 120(7):585\u2013591","journal-title":"Circulation"},{"key":"2859_CR9","doi-asserted-by":"crossref","unstructured":"Duval X et al (2010) Effect of early cerebral magnetic resonance imaging on clinical decisions in infective endocarditis: a prospective study. Ann Intern Med 152(8): 497\u2013504, w175","DOI":"10.7326\/0003-4819-152-8-201004200-00006"},{"issue":"8","key":"2859_CR10","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.3174\/ajnr.A3582","volume":"34","author":"A Hess","year":"2013","unstructured":"Hess A et al (2013) Brain MRI findings in neurologically asymptomatic patients with infective endocarditis. AJNR Am J Neuroradiol 34(8):1579\u20131584","journal-title":"AJNR Am J Neuroradiol"},{"issue":"5","key":"2859_CR11","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.carpath.2006.05.009","volume":"15","author":"G Thiene","year":"2006","unstructured":"Thiene G, Basso C (2006) Pathology and pathogenesis of infective endocarditis in native heart valves. Cardiovasc Pathol 15(5):256\u2013263","journal-title":"Cardiovasc Pathol"},{"issue":"5","key":"2859_CR12","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/jth.14736","volume":"18","author":"L Liesenborghs","year":"2020","unstructured":"Liesenborghs L et al (2020) Coagulation: at the heart of infective endocarditis. J Thromb Haemost 18(5):995\u20131008","journal-title":"J Thromb Haemost"},{"issue":"39","key":"2859_CR13","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.1093\/eurheartj\/ehad193","volume":"44","author":"V Delgado","year":"2023","unstructured":"Delgado V et al (2023) 2023 ESC Guidelines for the management of endocarditis. Eur Heart J 44(39):3948\u20134042","journal-title":"Eur Heart J"},{"issue":"5","key":"2859_CR14","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1159\/000538549","volume":"149","author":"C Morelli","year":"2024","unstructured":"Morelli C, Rocca B, Gigante B (2024) Infective endocarditis and antithrombotic therapy. Cardiology 149(5):513\u2013522","journal-title":"Cardiology"},{"issue":"2","key":"2859_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2023.100768","volume":"3","author":"T Caldonazo","year":"2024","unstructured":"Caldonazo T et al (2024) Antithrombotic therapy in patients with infective endocarditis: a systematic review and meta-analysis. JACC Adv 3(2):100768","journal-title":"JACC Adv"},{"issue":"10","key":"2859_CR16","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1111\/j.1462-5822.2011.01639.x","volume":"13","author":"K Seidl","year":"2011","unstructured":"Seidl K et al (2011) In vitro endothelial cell damage is positively correlated with enhanced virulence and poor vancomycin responsiveness in experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Cell Microbiol 13(10):1530\u201341","journal-title":"Cell Microbiol"},{"issue":"39","key":"2859_CR17","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1093\/eurheartj\/ehz175","volume":"40","author":"L Liesenborghs","year":"2019","unstructured":"Liesenborghs L et al (2019) Staphylococcus aureus endocarditis: distinct mechanisms of bacterial adhesion to damaged and inflamed heart valves. Eur Heart J 40(39):3248\u20133259","journal-title":"Eur Heart J"},{"issue":"4","key":"2859_CR18","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/cid\/ciad271","volume":"77","author":"VG Fowler","year":"2023","unstructured":"Fowler VG et al (2023) The 2023 Duke-International Society for Cardiovascular Infectious Diseases criteria for infective endocarditis: updating the modified Duke criteria. Clin Infect Dis 77(4):518\u2013526","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2859_CR19","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1161\/STROKEAHA.111.641423","volume":"43","author":"KR Lees","year":"2012","unstructured":"Lees KR et al (2012) Contemporary outcome measures in acute stroke research: choice of primary outcome measure. Stroke 43(4):1163\u20131170","journal-title":"Stroke"},{"issue":"11","key":"2859_CR20","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1161\/STROKEAHA.113.001470","volume":"44","author":"B Iung","year":"2013","unstructured":"Iung B et al (2013) Determinants of cerebral lesions in endocarditis on systematic cerebral magnetic resonance imaging: a prospective study. Stroke 44(11):3056\u20133062","journal-title":"Stroke"},{"issue":"11","key":"2859_CR21","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.4065\/mcp.2011.0111","volume":"86","author":"NS Anavekar","year":"2011","unstructured":"Anavekar NS et al (2011) Modifiers of symptomatic embolic risk in infective endocarditis. Mayo Clin Proc 86(11):1068\u201374","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"2859_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1086\/588663","volume":"47","author":"U Snygg-Martin","year":"2008","unstructured":"Snygg-Martin U et al (2008) Cerebrovascular complications in patients with left-sided infective endocarditis are common: a prospective study using magnetic resonance imaging and neurochemical brain damage markers. Clin Infect Dis 47(1):23\u201330","journal-title":"Clin Infect Dis"},{"key":"2859_CR23","unstructured":"Pinto P et al (2024) Impact of Neurological Complications on Long-Term Outcomes in Patients with Infective Endocarditis. Trop Med Infect Dis 9(6)"},{"issue":"1","key":"2859_CR24","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.1038\/s41598-020-60995-3","volume":"10","author":"CC Chen","year":"2020","unstructured":"Chen CC et al (2020) Long-term outcome of neurological complications after infective endocarditis. Sci Rep 10(1):3994","journal-title":"Sci Rep"},{"issue":"2","key":"2859_CR25","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GY Lip","year":"2010","unstructured":"Lip GY et al (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137(2):263\u2013272","journal-title":"Chest"},{"issue":"4","key":"2859_CR26","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1093\/ejcts\/ezs043","volume":"41","author":"SAM Nashef","year":"2012","unstructured":"Nashef SAM et al (2012) EuroSCORE II\u2020. Eur J Cardiothorac Surg 41(4):734\u2013745","journal-title":"Eur J Cardiothorac Surg"},{"key":"2859_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-8-49","volume":"8","author":"M Heiro","year":"2008","unstructured":"Heiro M et al (2008) Long-term outcome of infective endocarditis: a study on patients surviving over one year after the initial episode treated in a Finnish teaching hospital during 25 years. BMC Infect Dis 8:49","journal-title":"BMC Infect Dis"},{"issue":"1","key":"2859_CR28","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/s13104-017-2660-3","volume":"10","author":"A Barcelos","year":"2017","unstructured":"Barcelos A, Lamas C, Tibiri\u00e7a E (2017) Evaluation of microvascular endothelial function in patients with infective endocarditis using laser speckle contrast imaging and skin video-capillaroscopy: research proposal of a case control prospective study. BMC Res Notes 10(1):342","journal-title":"BMC Res Notes"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-026-02859-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-026-02859-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-026-02859-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T09:37:15Z","timestamp":1770629835000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-026-02859-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":28,"alternative-id":["2859"],"URL":"https:\/\/doi.org\/10.1007\/s00392-026-02859-w","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"24 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of the University of Regensburg, Germany (approval number 18\u2013925-101; approved March 2018).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"The requirement for written informed consent was waived by the Institutional Review Board based on the Bavarian Hospital Act.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent statement"}},{"value":"All authors declare no competing interests relevant to this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}